Paliperidone: A new atypical antipsychotic or more of the same?

Research output: Contribution to journalShort SurveyOtherpeer-review

Abstract

Paliperidone has now been approved for the treatment of schizophrenia. It is an active metabolite of risperidone in an extended-release formulation.

Original languageEnglish
Pages (from-to)68-69
Number of pages2
JournalMedicine Today
Volume10
Issue number7
Publication statusPublished - Jul 2009

Cite this